Considering Which Head or Heads May Roll for a Troubled Website Rollout



WASHINGTON — White House officials, asserting that the HealthCare.gov website is largely fixed, are under mounting pressure from Democrats and close allies to hold senior-level people accountable for the botched rollout of President Obama’s signature domestic achievement and to determine who should be fired.
For weeks, the president and his aides have said they are not interested in conducting a witch hunt in the middle of the effort to rescue the website. But in the West Wing, the desire for an explanation about how an administration that prides itself on competence bungled so badly remains an urgent mission.
“I assure you that I’ve been asking a lot of questions about that,” Mr. Obama said in a news conference last month, in comments that reverberated across the administration. The president warned, “There is going to be a lot of evaluation of how we got to this point.”
Officials declined to offer details about which government employees at the White House or other agencies might be under the microscope during any review of the development of the health care website. But there is a long list of people who have been publicly identified as key players. The possible targets include Kathleen Sebelius, the health and human services secretary; Marilyn Tavenner, the head of the Centers for Medicaid and Medicare Services; Mike Hash, the head of the health and human services health reform office; Michelle Snyder, the chief operating officer at Medicaid and Medicare; Henry Chao, the chief digital architect for the website; Jeanne Lambrew, the head of health care policy inside the White House; David Simas, a key adviser involved in the rollout; and Todd Park, the president’s top adviser on technology issues.
Close aides said that Mr. Obama was unlikely to give in to the demands for a public flogging, but White House officials also said that Mr. Obama had demonstrated a calculated willingness to push people out.
“He’s not someone who screams and yells at staff or who blames staff externally,” said one former senior White House staff member who declined to be identified discussing Mr. Obama’s approach to personnel decisions. But the former aide said that the president showed a clear ability to tell some of his closest advisers that they were “not the right person for this job at this time.”

On Dying After Your Time



HASTINGS-ON-HUDSON, N.Y. — THIS fall Google announced that it would venture into territory far removed from Internet search. Through a new company, Calico, it will be “tackling” the “challenge” of aging.
The announcement, though, was vague about what exactly the challenge is and how exactly Google means to tackle it. Calico may, with the aid of Big Data, simply intensify present efforts to treat the usual chronic diseases that afflict the elderly, like cancer, heart disease and Alzheimer’s. But there is a more ambitious possibility: to “treat” the aging process itself, in an attempt to slow it.
Of course, the dream of beating back time is an old one. Shakespeare had King Lear lament the tortures of aging, while the myth of Ponce de Leon’s Fountain of Youth in Florida and the eternal life of the Struldbrugs in “Gulliver’s Travels” both fed the notion of overcoming aging.
For some scientists, recent anti-aging research — on gene therapy, body-part replacement by regeneration and nanotechnology for repairing aging cells — has breathed new life into this dream. Optimists about average life expectancy’s surpassing 100 years in the coming century, like James W. Vaupel, the founder and director of the Max Planck Institute for Demographic Research in Germany, cite promising animal studies in which the lives of mice have been extended through genetic manipulation and low-calorie diets. They also point to the many life-extending medical advances of the past century as precedents, with no end in sight, and note that average life expectancy in the United States has long been rising, from 47.3 in 1900 to 78.7 in 2010. Others are less sanguine. S. Jay Olshansky, a research associate at the Center on Aging at the University of Chicago, has pointed out that sharp reductions in infant mortality explain most of that rise. Even if some people lived well into old age, the death of 50 percent or more of infants and children for most of history kept the average life expectancy down. As those deaths fell drastically over the past century, life expectancy increased, helped by improvements in nutrition, a decline in infectious disease and advances in medicine. But there is no reason to think another sharp drop of that sort is in the cards.
Even if anti-aging research could give us radically longer lives someday, though, should we even be seeking them? Regardless of what science makes possible, or what individual people want, aging is a public issue with social consequences, and these must be thought through.

Democrats’ Latest Campaign for Health Care Law Begins



WASHINGTON — President Obama and congressional Democrats, seizing on the good news of an improving health care website and rising enrollments, on Wednesday highlighted parts of the law that are popular with the public and reminded Americans, and the law’s opponents, of what would be lost if the Affordable Care Act were repealed.
As part of that political counteroffensive, which began this week, Democratic congresswomen challenged Republicans to present an alternative that would provide free preventive health services for the 105 million Americans who have already received them under the law. At the same time, the Democratic Congressional Campaign Committee singled out about 60 House Republicans, accusing them of plotting to take away immunizations for children, cancer screenings and mammograms.
The president’s aides said that with fixes in place online, they hoped a daily barrage of more positive messages about the health care law during the next several weeks — some to be delivered by Mr. Obama personally — would help refocus attention on its benefits. Mr. Obama addressed a White House Youth Summit meeting on Wednesday, and on Thursday he will talk about how the law prohibits insurance companies from discriminating against people with pre-existing medical conditions.
“Every day, there will be something coming out of the White House,” said one official, who was not authorized to talk publicly about the strategy and spoke on the condition of anonymity.
White House officials and congressional Democratic leaders said the effort was intended to get rank-and-file Democrats out of the defensive crouch they had been in for the past two months by countering the barrage of negative stories from Republicans. The push comes amid reports of a surge in enrollments since the administration announced improvements in the performance of the federal marketplace. About 29,000 people selected insurance plans on HealthCare.gov during the first two days of December, 3,000 more than the total who signed up over the whole month of October, according to people familiar with the numbers.
The battle over the president’s signature domestic achievement is far from over, but this week, for the first time since the rollout of HealthCare.gov on Oct. 1, Democrats seem prepared to fight.

Reviving the Fight for Single-Payer

Representative Jim McDermott of Washington wants to give states the tools to adopt it—at their own pace

By William Greider
The Nation, Dec. 4, 2013
When the media frenzy subsides and Republicans run out of scare stories, the country will be faced with the most important question about Obamacare: Can it deliver what it promised? Thanks to the Affordable Care Act, a new business model is rapidly emerging in the medical-industrial complex that, in theory, can dramatically reduce the inflated costs of healthcare while serving everyone—rich and poor, healthy and sick. But the reformed system will also still rely on the market competition of profit-making enterprises, including insurance companies. A lot of liberal Democrats, though they voted for Obama’s bill, remain skeptical.
“In the long arc of healthcare reform, I think [the ACA] will ultimately fail, because we are trying to put business-model methods into the healthcare system,” said Washington Representative Jim McDermott. “We’re not making refrigerators. We’re dealing with human beings, who are way more complicated than refrigerators on an assembly line.” I turned to the Seattle congressman for a candid assessment because he’s the third-ranking Democrat on the House Ways and Means Committee and has been an advocate of single-payer healthcare for decades. Plus, he’s a doctor.
The business transformation under way in healthcare involves the consolidation of hospitals, doctors and insurance companies in freestanding “integrated delivery systems”—nonprofit and profit-seeking—that will have the operating scope and power to eliminate duplications and waste and hold down costs, especially the incomes of primary-care doctors. Major hospitals are buying up other hospitals and private practices, and they’re hiring younger doctors as salaried employees. An  American Medical Association survey in 2012 found that a majority of doctors under 40 are employees, no longer independent practitioners.
“The medical-industrial complex is putting itself together so that the docs will be the least of our problem,” McDermott said. “They will simply be serfs working for the system.”  The AMA’s market research reports that “hospitals focus on employing primary-care physicians in order to maintain a strong referral base for high-margin specialty service lines.” Big hospitals need a feeder system of salaried doctors, McDermott explained, to keep sending them patients in need of surgery or other expensive procedures.
http://www.pnhp.org/print/news/2013/december/reviving-the-fight-for-single-payer

10 Questions: Steven Nissen, M.D.

By Todd Neal, Senior Staff Writer
MedPage Today, Dec. 5, 2013
What's the biggest barrier to practicing medicine today? That's just the first of 10 questions the MedPage Today staff is asking leading clinicians and researchers to get their personal views on their chosen profession. In this series we share their uncensored responses. Here, answers from Steven Nissen, MD, of the Cleveland Clinic.
There, Nissen is chair of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine. A past president of the American College of Cardiology and former chair of the FDA's Cardiovascular Renal Drugs Advisory Committee, he has had a leading role in highlighting potential risks associated with certain drugs, including rofecoxib (Vioxx) and rosiglitazone (Avandia). In 2007, Nissen was included on Time Magazine's list of "100 men and women whose power, talent, or moral example is transforming the world."
1. What's the biggest barrier to your practicing medicine today?
The lack of a single-payer system. We waste enormous amounts of time and energy dealing with insurance companies, whose major goal is figuring out how not to cover patients.
2. What is your most vivid memory involving a patient who could not afford to pay for healthcare (or meds or tests, etc.) and how did you respond?
There are too many to count. I remember a patient who could not afford clopidogrel (Plavix), so he split his pills to stretch the prescription, but subsequently had a catastrophic in-stent thrombosis leading to cardiogenic shock and eventually heart transplantation.
3. What do you most often wish you could say to patients, but don't?
If you continue to smoke, I would prefer that you see another physician.
4. If you could change or eliminate something about the healthcare system, what would it be?
Fee-for-service medicine. It drives overutilization and leads to poor outcomes.


Nobody Should Get Rich Off Obamacare

By Evan Soltas
Bloomberg, The Ticker, Dec. 3, 2013
For an industry that's supposed to be burdened by the launch of Obamacare, the health-care business is doing pretty well. Stocks of health-care companies are up almost 40 percent this year, the strongest performance of any sector in the S&P 500.
This is despite, for insurers, new regulations on the "medical loss ratio" which require them to spend at least 80 percent of premiums on health care -- in practice, capping their profits and administrative expenses such as advertising at 20 percent. How about the medical-technology manufacturers that were slapped with an excise tax? Doing just fine. The hospital chains that face lower reimbursement rates from Medicare patients? They're doing well, too.
Health care is a business, and businesses are supposed to make money. Still, it's a bit concerning that health-care investors are so upbeat just as President Barack Obama's health-reform law goes into effect.
It makes you wonder where the new profits are expected to come from. If they're earned in a competitive market, great -- but health care in the U.S. hasn’t been a free market in decades, so it’s worth turning a skeptical eye.
The law will give the insurance industry millions of new customers and subsidizes its products. It brings millions of others into the market for health-care services through its Medicaid expansion. If health-care investors are throwing a party, it might be because the rest of us are paying for it.
Economists call profits in excess of what would be earned in a competitive market "rents." Often it's hard to tell the difference -- but the expected increase in health-care profits has a whiff of rent about it. After all, Obama passed his law with the support of the health-care industry. The insurers signed on. Pharma signed on. Doctors signed on. It would be shocking if this law reduced their rents.